Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
<h4>Aims</h4>To compare the baseline cardiovascular characteristics of immunoglobulin light-chain (AL) and amyloid transthyretin (ATTR) cardiac amyloidosis (CA) and to investigate patients' contemporary cardiac outcomes.<h4>Methods</h4>Single-center analysis of clinical,...
Enregistré dans:
| Auteurs principaux: | Osnat Itzhaki Ben Zadok, Mordehay Vaturi, Iuliana Vaxman, Zaza Iakobishvili, Noa Rhurman-Shahar, Ran Kornowski, Ashraf Hamdan |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ec6cc53fbda64369b6e914aa9b515cb7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
par: Sebastiaan HC Klaassen, et autres
Publié: (2020) -
Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina
par: Maria S. Saez, et autres
Publié: (2021) -
Light-chain cardiac amyloidosis with neuropathy: a case report
par: Xu ZW, et autres
Publié: (2015) -
Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study
par: Shelly Meron Grossman, et autres
Publié: (2021) -
Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
par: Guido Primiano, et autres
Publié: (2021)